Intimation of Re-Scheduling of the Earning Concall under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015.
3BBLACKBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
3B BlackBio Dx Ltd has informed the stock exchanges that it is rescheduling its earnings conference call for investors and analysts. The call was originally planned for Wednesday, February 18, 2026 at 4:00 PM IST and will now be held on Saturday, February 21, 2026 at 12:00 PM IST. The reason given is 'certain unavoidable circumstances.' The call will discuss the company's operational and financial performance for the quarter and nine months ended December 31, 2025 (Q3FY26 and 9MFY26). Management will be represented by Chairman & MD Dhirendra Dubey and Whole Time Director Nikhil Kuber Dubey, with Nuvama Wealth Research coordinating.
This is a purely procedural update with no impact on the company's fundamentals or financials. Investors should note the new date to participate in the call, but the postponement by three days does not affect the underlying Q3FY26 results, which remain on track to be discussed as scheduled.